Xilio Therapeutics, Inc. (XLO)
NASDAQ · Healthcare
Xilio Therapeutics, Inc. Cash Flow 2024–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Operating Cash Flow | -5.0M | -18.4M | -68.6M | -75.7M | -80.8M | -36.1M |
| Depreciation & Amort. | — | — | — | — | — | — |
| Investing Activities | ||||||
| Capital Expenditure | 518,000 | 36,000 | 486,000 | 1.9M | 1.1M | 2.2M |
| Free Cash Flow | -5.5M | -18.4M | -69.1M | -77.6M | -81.9M | -38.3M |
| Financing Activities | ||||||
| Dividends Paid | — | — | — | — | — | — |
| Stock Buybacks | — | — | — | — | — | — |
Xilio Therapeutics, Inc. Cash Flow — FAQ
Xilio Therapeutics, Inc. (XLO) cash flow over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see XLO's cash flow history?
The chart and table above show Xilio Therapeutics, Inc.'s cash flow by year and by quarter, including the growth rate.